SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $210.17 million. The enterprise value is $179.16 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 67.58 million shares outstanding. The number of shares has increased by 2.18% in one year.
Current Share Class | 67.58M |
Shares Outstanding | 67.58M |
Shares Change (YoY) | +2.18% |
Shares Change (QoQ) | +0.71% |
Owned by Insiders (%) | 6.46% |
Owned by Institutions (%) | 40.10% |
Float | 50.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.98 |
Forward PS | 2.49 |
PB Ratio | 2.74 |
P/TBV Ratio | 4.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.57 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.83.
Current Ratio | 3.39 |
Quick Ratio | 3.03 |
Debt / Equity | 0.83 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -27.07 |
Financial Efficiency
Return on equity (ROE) is -74.09% and return on invested capital (ROIC) is -28.82%.
Return on Equity (ROE) | -74.09% |
Return on Assets (ROA) | -23.46% |
Return on Invested Capital (ROIC) | -28.82% |
Return on Capital Employed (ROCE) | -47.04% |
Revenue Per Employee | $164,747 |
Profits Per Employee | -$173,511 |
Employee Count | 423 |
Asset Turnover | 0.39 |
Inventory Turnover | 3.52 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $2.01 million in taxes.
Income Tax | 2.01M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.51% in the last 52 weeks. The beta is 1.01, so SOPHiA GENETICS's price volatility has been similar to the market average.
Beta (5Y) | 1.01 |
52-Week Price Change | -2.51% |
50-Day Moving Average | 3.24 |
200-Day Moving Average | 3.30 |
Relative Strength Index (RSI) | 44.19 |
Average Volume (20 Days) | 85,893 |
Short Selling Information
The latest short interest is 18,389, so 0.03% of the outstanding shares have been sold short.
Short Interest | 18,389 |
Short Previous Month | 35,777 |
Short % of Shares Out | 0.03% |
Short % of Float | 0.04% |
Short Ratio (days to cover) | 0.46 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $69.69 million and -$73.40 million in losses. Loss per share was -$1.10.
Revenue | 69.69M |
Gross Profit | 47.23M |
Operating Income | -67.34M |
Pretax Income | -66.00M |
Net Income | -73.40M |
EBITDA | -65.91M |
EBIT | -67.34M |
Loss Per Share | -$1.10 |
Full Income Statement Balance Sheet
The company has $94.82 million in cash and $63.81 million in debt, giving a net cash position of $31.01 million or $0.46 per share.
Cash & Cash Equivalents | 94.82M |
Total Debt | 63.81M |
Net Cash | 31.01M |
Net Cash Per Share | $0.46 |
Equity (Book Value) | 76.69M |
Book Value Per Share | 1.13 |
Working Capital | 82.55M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$36.72 million and capital expenditures -$263,000, giving a free cash flow of -$36.99 million.
Operating Cash Flow | -36.72M |
Capital Expenditures | -263,000 |
Free Cash Flow | -36.99M |
FCF Per Share | -$0.55 |
Full Cash Flow Statement Margins
Gross margin is 67.78%, with operating and profit margins of -96.62% and -105.32%.
Gross Margin | 67.78% |
Operating Margin | -96.62% |
Pretax Margin | -102.43% |
Profit Margin | -105.32% |
EBITDA Margin | -94.57% |
EBIT Margin | -96.62% |
FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.18% |
Shareholder Yield | -2.18% |
Earnings Yield | -34.92% |
FCF Yield | -17.60% |
Analyst Forecast
The average price target for SOPHiA GENETICS is $7.00, which is 125.08% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 125.08% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 25.74% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -2.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.71 |
Piotroski F-Score | 2 |